Article metrics

Download PDFPDF

661 Initial results from a phase 1a/b study of IK-175, an oral AHR inhibitor, as a single agent and in combination with nivolumab in patients with advanced solid tumors and urothelial carcinoma
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022308021
Dec 202264011
Jan 2023126027
Feb 202380016
Mar 2023148026
Apr 20236806
May 202372010
Jun 20238008
Jul 202368010
Aug 20237206
Sep 20237208
Oct 20236603
Nov 2023126010
Dec 202310007
Jan 20242602
Total14760171